IFN�� is often a effective immunomodulator that has a variety of consequences on the lungs. However considered unusual, nearly all described instances of undesirable lung negative effects linked to IFN�� incorporate a great exacerbation involving asthma attack [15], pleural effusion [16], a great activation involving sarcoidosis [17], bronchiolitis obliterans-organizing pneumonia [18], along with